Abstract
Purpose
Obesity, insulin resistance, and puberty seem to influence and been inversely associated with 25-hydroxy vitamin D (25OHD) levels. To our knowledge, a study on 25OHD in children and adolescents with Prader–Willi syndrome (PWS), a genetic form of obesity, is not yet available.
Objective
To analyze the 25OHD values in pediatric PWS subjects in comparison with a control group (CNT), highlighting the possible correlations with IR, BMD, body composition, pubertal stage, and GH therapy (GHT).
Methods
Auxological and laboratory parameters, HOMA-IR, Vitamin D status, and bone density and body composition by DEXA scan were analyzed in 52 PWS and 110 controls (CNT), gender-, age-, and BMI-SD matched. None of them was on calcium or vitamin D. 20 PWS were on growth hormone (GH) therapy and 32 were previously treated.
Results and conclusion
Altogether, PWS had similar values of 25OHD compared to CNT.16 PWS (30.7%) and 27 CNT (24.5%) had low 25OHD levels (< 20 ng/ml) (p = NS). 25OHD of PWS on GHT were comparable to those previously treated. In both groups, univariate analysis showed a negative correlation between 25OHD and fat mass% (FM%). GH therapy and pubertal stage were positively correlated with bone parameters analyzed by DXA. Multivariate regression confirmed only FM% as negative predictor of 25HOD in PWS patients, as previously described. GHT does not seem to influence 25OHD in PWS.
Conclusion
Our data showed that PWS had similar values of 25OHD compared to CNT. As already described, FM seems to be the only parameter influencing 25OHD levels. Finally, GHT does not seem to influence 25OHD metabolism in PWS.
This is a preview of subscription content, log in via an institution to check access.
References
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader–Willi syndrome. Genet Med 14:10–26
Angulo MA, Butler MG, Cataletto ME (2015) Prader–Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38(12):1249–1263. https://doi.org/10.1007/s40618-015-0312-9
Saneei P, Salehi-Abargouei A, Esmaillzadeh A (2013) Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and metaanalysis. Obes Rev 14(5):393–404
Cediel G, Corvalán C, Aguirre C, de Romaña DL, Uauy R (2016) Serum 25-hydroxyvitamin D associated with indicators of body fat and insulin resistance in prepubertal Chilean children. Int J Obes (Lond) 40(1):147–152
Walker GE, Ricotti R, Roccio M, Moia S, Bellone S, Prodam F, Bona G (2014) Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS One 9(1):e83685
Cediel G, Corvalán C, López de Romaña D, Mericq V, Uauy R (2016) Prepubertal adiposity, vitamin D status, and insulin resistance. Pediatrics 138(1). doi:10.1542/peds.2016-0076
Fintini D, Grugni G, Bocchini S, Brufani C, Di Candia S, Corrias A, Delvecchio M, Salvatoni A, Ragusa L, Greggio N, Franzese A, Scarano E, Trifirò G, Mazzanti L, Chiumello G, Cappa M, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) (2016) Disorders of glucose metabolism in Prader–Willi syndrome: results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis 26(9):842–847
Purtell L, Viardot A, Campbell LV (2016) Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndrome. Endocrine 53(2):619–620
Savanelli MC, Scarano E, Muscogiuri G, Barrea L, Vuolo L, Rubino M, Savastano S, Colao A, Di Somma C (2016) Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D. Endocrine 52(1):111–119
Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P, Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W (2016) Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 101(2):394–415
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243
Tanner JM (1962) Growth at adolescence, 2nd edn. Balckwell Scientific Publications, Oxford
Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7(2):137–145
Fintini D, Brufani C, Grossi A, Ubertini G, Fiori R, Pecorelli L, Calzolari A, Cappa M (2011) Gender differences in bone mineral density in obese children during pubertal development. J Endocrinol Invest 34(4):e86–e91
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
No disclosure for any prior publication or submission. No conflict of interest or role of any sponsor is present in this work. All authors have read and agreed to this submission and to the transfer of copyright, and should it be accepted.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual/parents/guardians participants included in the study.
Rights and permissions
About this article
Cite this article
Fintini, D., Pedicelli, S., Bocchini, S. et al. 25OH vitamin D levels in pediatric patients affected by Prader–Willi syndrome. J Endocrinol Invest 41, 739–742 (2018). https://doi.org/10.1007/s40618-017-0781-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0781-0